NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways

Jun Cui,Liang Zhu,Xiaojun Xia,Helen Y. Wang,Xavier Legras,Jun Hong,Jiabing Ji,Pingping Shen,Shu Zheng,Zhijian J. Chen,Rong-Fu Wang

DOI: https://doi.org/10.1016/j.cell.2010.03.040

IF: 64.5

2010-04-01

Cell

Abstract:Stringent control of the NF-kappaB and type I interferon signaling pathways is critical to effective host immune responses, yet the molecular mechanisms that negatively regulate these pathways are poorly understood. Here, we show that NLRC5, a member of the highly conserved NOD-like protein family, can inhibit the IKK complex and RIG-I/MDA5 function. NLRC5 inhibited NF-kappaB-dependent responses by interacting with IKKalpha and IKKbeta and blocking their phosphorylation. It also interacted with RIG-I and MDA5, but not with MAVS, to inhibit RLR-mediated type I interferon responses. Consistent with these observations, NLRC5-specific siRNA knockdown not only enhanced the activation of NF-kappaB and its responsive genes, TNF-alpha and IL-6, but also promoted type I interferon signaling and antiviral immunity. Our findings identify NLRC5 as a negative regulator that blocks two central components of the NF-kappaB and type I interferon signaling pathways and suggest an important role for NLRC5 in homeostatic control of innate immunity.

cell biology,biochemistry & molecular biology